We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

140 hedge funds and large institutions have $146M invested in Bionano Genomics in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 44 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $6.56M | Put options by funds: $2.96M

29% more capital invested

Capital invested by funds: $114M → $146M (+$32.9M)

0% less ownership

Funds ownership: 0.05% → 0.05% (-0%)

2% less funds holding

Funds holding: 143 → 140 (-3)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

23% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 44

Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
44
Closed
20
Calls
$6.56M
Puts
$2.96M
Net Calls
+$3.6M
Net Calls Change
+$2.37M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$2.35M
2
BlackRock
BlackRock
New York
+$1.31M
3
Morgan Stanley
Morgan Stanley
New York
+$690K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$589K
5
Goldman Sachs
Goldman Sachs
New York
+$342K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.95M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.77M
3
Allianz Asset Management
Allianz Asset Management
Germany
-$1.7M
4
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$1.42M
5
Two Sigma Investments
Two Sigma Investments
New York
-$712K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
76
Millennium Management
New York
$58K +$68.7K +52 New
Lazard Asset Management
77
Lazard Asset Management
New York
$54K – – –
VCP
78
Verus Capital Partners
Arizona
$51K – – –
CIM
79
CIM Investment Management
Pennsylvania
$49K – – –
FDCDDQ
80
Federation des caisses Desjardins du Quebec
Quebec, Canada
$48.7K -$6.61K -5 -10%
KAS
81
Kestra Advisory Services
Texas
$45K -$15.9K -12 -23%
Man Group
82
Man Group
United Kingdom
$45K +$54.2K +41 New
AWM
83
AE Wealth Management
Kansas
$41K -$3.96K -3 -8%
AIP
84
Ameritas Investment Partners
Nebraska
$40K – – –
Prudential Financial
85
Prudential Financial
New Jersey
$39K – – –
WTB
86
Washington Trust Bank
Washington
$38K – – –
PAMS
87
Pictet Asset Management (Switzerland)
Switzerland
$37K – – –
Mackenzie Financial
88
Mackenzie Financial
Ontario, Canada
$36K -$3.96K -3 -9%
GKWIM
89
Gerber Kawasaki Wealth & Investment Management
California
$36K – – –
JWCA
90
J.W. Cole Advisors
Florida
$36K – – –
MLICM
91
Metropolitan Life Insurance Company (MetLife)
New York
$32.3K +$11.9K +9 +45%
BBVA
92
Banco Bilbao Vizcaya Argentaria
Spain
$31K – – –
Canada Pension Plan Investment Board
93
Canada Pension Plan Investment Board
Ontario, Canada
$30K -$35.7K -27 -50%
X
94
Xponance
Pennsylvania
$30K +$1.32K +1 +4%
AGM
95
Alpine Global Management
New York
$29K – – –
AWM
96
Apollon Wealth Management
South Carolina
$28K +$34.3K +26 New
Barclays
97
Barclays
United Kingdom
$27K -$5.29K -4 -14%
Nisa Investment Advisors
98
Nisa Investment Advisors
Missouri
$27K +$14.5K +11 +138%
RSWM
99
Robertson Stephens Wealth Management
California
$27K +$33K +25 New
LDFR
100
Lehman & Derafelo Financial Resources
Pennsylvania
$26K – – –
2 3
4
5 6

BNGO Hedge Fund Activity: Q3 2022 in Review

140 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2022, worth a combined $146M — up 29% from $114M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of BNGO and 17 opened new positions — a net loss of 3 holders — while 44 trimmed existing stakes and 34 added.

The largest buyer was State Street, adding an estimated $2.35M. The largest seller was Renaissance Technologies, cutting an estimated $4.95M.

  • 140 institutional investors held Bionano Genomics (BNGO) as of Q3 2022, down from 143 in Q2 2022.
  • Funds reported $146M of Bionano Genomics stock for Q3 2022, up 29% quarter-over-quarter.
  • 17 funds opened new Bionano Genomics positions in Q3 2022 and 20 closed out, a net change of -3 holders.
  • The largest Bionano Genomics buyer in Q3 2022 was State Street, an estimated $2.35M added.
  • The largest Bionano Genomics seller in Q3 2022 was Renaissance Technologies, an estimated $4.95M sold.

Based on aggregated 13F filings for Q3 2022.